-->

Tech Seeker (TS)

ZyVersa Therapeutics (AKA:Variant Pharmaceuticals Inc)
Profile last edited on: 3/23/2022

Clinical stage specialty biopharmaceutical company
TS Type
Small Corporation
Status
Active
Year Founded
2014
Last Involved Year
2019

Key People / Management

Location Information

2200 N Commerce Pkwy Suite 208
Weston, FL 33326
   (954) 529-2109
   www.zyversa.com

Public Profile

ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs. Our focus is on patients with inflammatory or renal diseases who have high unmet medical needs. Our clinical pipeline includes a phase 2a-ready asset, VAR 200, a cholesterol efflux mediator for treatment of focal segmental glomerulosclerosis (FSGS), and a novel inflammasome inhibitor with potential for multiple inflammatory diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
12
Revenue
N/A
Public/Private
Privately Held
Stock Info
---
Received SBIR $$
No

SBIR firms in the news

There are no news available.